Journal Article Citation:
Andersen, F., Viitanen, M., Halvorsen, DS., Straume, B., & Engstad, TA. (2011). Co-Morbidity and Drug Treatment in Alzheimer’s disease. U.S National Library of Medicine, 11(58), n.p. doi: 10.1186/1471-2318-11-58
Type of study (i.e. prospective cohort):
This is a cross-sectional study on co-morbidity and drug treatment of Alzheimer’s disease in northern Norway.
Sample/population:
The sample included people who had and did not have Alzheimer’s disease. There were 187 subjects who had just recently been diagnosed with Alzheimer’s. 500 participants who did not have cognitive symptoms were randomly selected to complete the advanced clinical and cognitive testing. A final group of cognitively healthy people had a total of 200 people.
Exposure (if applicable):
The exposure was the use of drug treatments.
Outcome (if applicable):
The outcome was the comparison of …show more content…
A Case-Control Study of Alzheimer’s Disease. U.S National Library of Medicine, 28(6), 766-74. https://www.ncbi.nlm.nih.gov/pubmed/2285263.
Type of study (i.e. prospective cohort):
This study is a case-control study. It also included a matched pairs design.
Sample/population:
The sample included 183 clinically diagnosed patients through the Geriatric and Family Services clinic at the University of Washington Hospital. It also included 18 patients found through the Veteran’s Administration Medical Center in Washington.
Exposure (if applicable):
The exposures were family history of Alzheimer’s/Dementia and viral or immune-related medical conditions relative to Alzheimer’s.
Outcome (if applicable):
The outcome is the risk of Alzheimer’s disease.
Study Purpose/Rationale:
This case-control study was created to measure the relation of a family history of Alzheimer’s and viral and immune-related medical conditions to the risk of developing Alzheimer’s
Andersen, F., Viitanen, M., Halvorsen, DS., Straume, B., & Engstad, TA. (2011). Co-Morbidity and Drug Treatment in Alzheimer’s disease. U.S National Library of Medicine, 11(58), n.p. doi: 10.1186/1471-2318-11-58
Type of study (i.e. prospective cohort):
This is a cross-sectional study on co-morbidity and drug treatment of Alzheimer’s disease in northern Norway.
Sample/population:
The sample included people who had and did not have Alzheimer’s disease. There were 187 subjects who had just recently been diagnosed with Alzheimer’s. 500 participants who did not have cognitive symptoms were randomly selected to complete the advanced clinical and cognitive testing. A final group of cognitively healthy people had a total of 200 people.
Exposure (if applicable):
The exposure was the use of drug treatments.
Outcome (if applicable):
The outcome was the comparison of …show more content…
A Case-Control Study of Alzheimer’s Disease. U.S National Library of Medicine, 28(6), 766-74. https://www.ncbi.nlm.nih.gov/pubmed/2285263.
Type of study (i.e. prospective cohort):
This study is a case-control study. It also included a matched pairs design.
Sample/population:
The sample included 183 clinically diagnosed patients through the Geriatric and Family Services clinic at the University of Washington Hospital. It also included 18 patients found through the Veteran’s Administration Medical Center in Washington.
Exposure (if applicable):
The exposures were family history of Alzheimer’s/Dementia and viral or immune-related medical conditions relative to Alzheimer’s.
Outcome (if applicable):
The outcome is the risk of Alzheimer’s disease.
Study Purpose/Rationale:
This case-control study was created to measure the relation of a family history of Alzheimer’s and viral and immune-related medical conditions to the risk of developing Alzheimer’s